MktsMarkets

Coya Therapeutics, Inc.
NASDAQ: COYAKey statistics
COYA News
Stories mentioning COYA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 251.00 | 3,960 | 3,564 | 164.00 | 258.00 | 2.00 | 0.00 | 3,425 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | 7,891 | 9,991 | 5,997 | 6,578 | 7,935 | 4,083 | 4,450 | 6,661 |
| Operating Income (Loss) | (7,640) | (6,030) | (2,433) | (6,415) | (7,677) | (4,081) | (4,450) | (3,236) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 433.00 | 325.00 | 317.00 | 320.00 | 370.00 | 445.00 | 429.00 | 344.00 |
| Pretax Income | (7,207) | (6,095) | (7,307) | (2,892) | ||||
| Tax Provision | 0.00 | 0.00 | ||||||
| Net Income (Loss) | (7,207) | (5,708) | (2,116) | (6,095) | (7,307) | (2,916) | (4,021) | (2,892) |
| Earnings Per Share (Basic) | (0.32) | (0.34) | (0.13) | (0.36) | (0.44) | (0.19) | (0.26) | (0.19) |
| Earnings Per Share (Diluted) | (0.32) | (0.34) | (0.13) | (0.36) | (0.44) | (0.19) | (0.26) | (0.19) |
| Weighted Average Shares Outstanding (Basic) | 22,644 | 16,730 | 16,733 | 16,725 | 16,721 | 15,239 | 15,221 | 14,915 |
| Weighted Average Shares Outstanding (Diluted) | 22,644 | 16,730 | 16,733 | 16,725 | 16,721 | 15,239 | 15,221 | 14,915 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About COYA
Coya Therapeutics, Inc. (NASDAQ: COYA) is a stock listed on the Nasdaq Stock Market under the ticker symbol COYA. It last traded at $2.95 (Nov 20, 2026, 4:00 PM ET), down 1.0% on the day. That gives Coya Therapeutics a market capitalisation of $69.9M.
Over the past 52 weeks COYA has traded between $2.72 and $6.62.
Revenue for the quarter ended Mar 31, 2026 was $251.0K; a net loss of $7.2M. Revenue was down 2.7% from $258.0K in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $251.0K | -$7.2M | -2871.3% |
| Dec 31, 2025 | $4.0M | -$5.7M | -144.1% |
| Sep 30, 2025 | $3.6M | -$2.1M | -59.4% |
| Jun 30, 2025 | $164.0K | -$6.1M | -3716.5% |
From Coya Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…